A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

This study has been terminated.
(Diakron Pharmaceuticals couldn't fulfill the financial responsibility of the study)
Drug Research Unit Ghent, Ghent, Belgium
Kinesis Pharma BV, Breda, the Netherlands
Information provided by (Responsible Party):
Diakron Pharmaceuticals
ClinicalTrials.gov Identifier:
First received: July 19, 2012
Last updated: February 23, 2015
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)